Updated October 7, 2026
Where our services are available
Our clinical partner MDI has clinician coverage across the 50 U.S. states. Our current GLP-1 weight-management program is available for evaluation in 48 states: Louisiana (LA) and Mississippi (MS) are excluded. This restriction applies to our current program; it does not mean all weight-loss care is prohibited in those states.
Other programs depend on the patient's location, the applicable clinician and the medication and pharmacy available for that patient. A state's clinician coverage does not guarantee that every medication or program is available. District of Columbia and U.S. territories are not currently included in this website's enrollment coverage.
GLP-1 state list
| State | GLP-1 evaluation |
|---|---|
| Alabama (AL) | Available for clinician evaluation |
| Alaska (AK) | Available for clinician evaluation |
| Arizona (AZ) | Available for clinician evaluation |
| Arkansas (AR) | Available for clinician evaluation |
| California (CA) | Available for clinician evaluation |
| Colorado (CO) | Available for clinician evaluation |
| Connecticut (CT) | Available for clinician evaluation |
| Delaware (DE) | Available for clinician evaluation |
| Florida (FL) | Available for clinician evaluation |
| Georgia (GA) | Available for clinician evaluation |
| Hawaii (HI) | Available for clinician evaluation |
| Idaho (ID) | Available for clinician evaluation |
| Illinois (IL) | Available for clinician evaluation |
| Indiana (IN) | Available for clinician evaluation |
| Iowa (IA) | Available for clinician evaluation |
| Kansas (KS) | Available for clinician evaluation |
| Kentucky (KY) | Available for clinician evaluation |
| Louisiana (LA) | Currently unavailable |
| Maine (ME) | Available for clinician evaluation |
| Maryland (MD) | Available for clinician evaluation |
| Massachusetts (MA) | Available for clinician evaluation |
| Michigan (MI) | Available for clinician evaluation |
| Minnesota (MN) | Available for clinician evaluation |
| Mississippi (MS) | Currently unavailable |
| Missouri (MO) | Available for clinician evaluation |
| Montana (MT) | Available for clinician evaluation |
| Nebraska (NE) | Available for clinician evaluation |
| Nevada (NV) | Available for clinician evaluation |
| New Hampshire (NH) | Available for clinician evaluation |
| New Jersey (NJ) | Available for clinician evaluation |
| New Mexico (NM) | Available for clinician evaluation |
| New York (NY) | Available for clinician evaluation |
| North Carolina (NC) | Available for clinician evaluation |
| North Dakota (ND) | Available for clinician evaluation |
| Ohio (OH) | Available for clinician evaluation |
| Oklahoma (OK) | Available for clinician evaluation |
| Oregon (OR) | Available for clinician evaluation |
| Pennsylvania (PA) | Available for clinician evaluation |
| Rhode Island (RI) | Available for clinician evaluation |
| South Carolina (SC) | Available for clinician evaluation |
| South Dakota (SD) | Available for clinician evaluation |
| Tennessee (TN) | Available for clinician evaluation |
| Texas (TX) | Available for clinician evaluation |
| Utah (UT) | Available for clinician evaluation |
| Vermont (VT) | Available for clinician evaluation |
| Virginia (VA) | Available for clinician evaluation |
| Washington (WA) | Available for clinician evaluation |
| West Virginia (WV) | Available for clinician evaluation |
| Wisconsin (WI) | Available for clinician evaluation |
| Wyoming (WY) | Available for clinician evaluation |
Before you enroll
Select the state where you will be physically located for care. Our GLP-1 enrollment does not proceed for Louisiana or Mississippi. A clinician determines eligibility and any prescription; medication availability and pharmacy delivery must be confirmed separately.
Questions about availability? Contact kenny@eternal-springs.com or 626-616-5715.